Relay Therapeutics has laid off about 70 employees, the biotech's third round of cuts in less than a year.  | Relay ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

Shortly after President Donald Trump took office this January, the White House rolled out an initiative designed to slash ...

FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency.  | The FDA’s Chief Medical Officer ...

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...

Brown University has reportedly become the fifth university to be targeted by the Trump administration for funding cuts, ...

After a drawn-out acquisition that closed in 2023, U.K. biotech F-star Therapeutics is charting its own path as a private, ...

In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent ...

As the Department of Health and Human Services grapples with the fallout of mass layoffs directed by Secretary Robert F.

BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years after Novartis handed back the anti-TIGIT ...

Roche has reported preliminary results on its Alzheimer’s disease prospect trontinemab. | Roche has reported preliminary ...